Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chondrocytes | 10 | 2016 | 147 | 1.290 |
Why?
|
| SOX9 Transcription Factor | 6 | 2016 | 14 | 1.150 |
Why?
|
| Protein Kinase C | 13 | 2003 | 41 | 0.780 |
Why?
|
| Mitogen-Activated Protein Kinases | 13 | 2003 | 23 | 0.770 |
Why?
|
| Cell Differentiation | 8 | 2016 | 111 | 0.570 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2014 | 39 | 0.540 |
Why?
|
| Gene Expression Regulation | 2 | 2016 | 215 | 0.530 |
Why?
|
| Collagen Type II | 4 | 2016 | 20 | 0.500 |
Why?
|
| Signal Transduction | 11 | 2009 | 354 | 0.470 |
Why?
|
| Chondrogenesis | 5 | 2003 | 32 | 0.460 |
Why?
|
| Isoenzymes | 8 | 2002 | 45 | 0.420 |
Why?
|
| Mesoderm | 8 | 2003 | 18 | 0.410 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 6 | 2000 | 14 | 0.360 |
Why?
|
| Apoptosis | 5 | 2003 | 172 | 0.360 |
Why?
|
| Animals | 19 | 2016 | 3025 | 0.360 |
Why?
|
| Genome | 1 | 2010 | 8 | 0.340 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 7 | 2003 | 16 | 0.270 |
Why?
|
| Cartilage | 6 | 2010 | 96 | 0.260 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 11 | 2003 | 22 | 0.220 |
Why?
|
| Nitric Oxide | 5 | 2003 | 55 | 0.220 |
Why?
|
| Cartilage, Articular | 3 | 2003 | 389 | 0.220 |
Why?
|
| Cells, Cultured | 9 | 2016 | 390 | 0.220 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2003 | 48 | 0.200 |
Why?
|
| Enzyme Activation | 9 | 2003 | 82 | 0.200 |
Why?
|
| Chick Embryo | 8 | 2003 | 15 | 0.200 |
Why?
|
| Binding Sites | 2 | 2014 | 55 | 0.200 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 8 | 2003 | 28 | 0.190 |
Why?
|
| Mice | 6 | 2016 | 1128 | 0.190 |
Why?
|
| Macrophages | 2 | 1999 | 85 | 0.190 |
Why?
|
| Caspases | 5 | 2003 | 22 | 0.190 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 124 | 0.190 |
Why?
|
| Sirolimus | 1 | 2001 | 11 | 0.180 |
Why?
|
| Immunosuppressive Agents | 1 | 2001 | 99 | 0.170 |
Why?
|
| Receptors, Vitronectin | 1 | 2000 | 5 | 0.170 |
Why?
|
| Receptors, Laminin | 1 | 1999 | 1 | 0.160 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2016 | 7 | 0.160 |
Why?
|
| Enzyme Inhibitors | 7 | 2003 | 92 | 0.130 |
Why?
|
| Introns | 1 | 2016 | 16 | 0.130 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2016 | 3 | 0.130 |
Why?
|
| Osteoblasts | 1 | 2016 | 53 | 0.130 |
Why?
|
| Protein Binding | 2 | 2014 | 101 | 0.120 |
Why?
|
| Osteogenesis | 1 | 2016 | 96 | 0.120 |
Why?
|
| Cadherins | 4 | 2003 | 29 | 0.120 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2014 | 1 | 0.120 |
Why?
|
| Nucleotide Motifs | 1 | 2014 | 2 | 0.120 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 18 | 0.110 |
Why?
|
| Protein Transport | 1 | 2014 | 32 | 0.110 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 36 | 0.110 |
Why?
|
| Trans-Activators | 3 | 2003 | 19 | 0.110 |
Why?
|
| Cell Line | 3 | 2010 | 222 | 0.110 |
Why?
|
| Gene Expression | 1 | 2014 | 166 | 0.110 |
Why?
|
| Mice, Knockout | 1 | 2014 | 256 | 0.110 |
Why?
|
| Rats | 2 | 2016 | 554 | 0.100 |
Why?
|
| Down-Regulation | 4 | 2016 | 78 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2003 | 130 | 0.100 |
Why?
|
| Cell Division | 3 | 2001 | 72 | 0.100 |
Why?
|
| Caspase 3 | 5 | 2003 | 16 | 0.100 |
Why?
|
| Fibronectins | 3 | 2000 | 15 | 0.090 |
Why?
|
| Cell Adhesion | 3 | 2000 | 23 | 0.090 |
Why?
|
| Protein Kinase C-alpha | 5 | 2002 | 7 | 0.090 |
Why?
|
| Limb Buds | 2 | 2009 | 2 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2003 | 259 | 0.090 |
Why?
|
| Rabbits | 4 | 2003 | 166 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2010 | 6 | 0.090 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 25 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 46 | 0.080 |
Why?
|
| Gene Regulatory Networks | 1 | 2010 | 24 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2000 | 29 | 0.080 |
Why?
|
| Integrins | 2 | 2000 | 12 | 0.080 |
Why?
|
| Body Patterning | 1 | 2009 | 3 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2009 | 57 | 0.080 |
Why?
|
| Cytoskeletal Proteins | 3 | 2003 | 16 | 0.070 |
Why?
|
| Bone and Bones | 1 | 2009 | 109 | 0.070 |
Why?
|
| Phosphorylation | 3 | 2001 | 122 | 0.070 |
Why?
|
| Collagen | 3 | 2003 | 78 | 0.070 |
Why?
|
| Flavonoids | 5 | 2003 | 16 | 0.060 |
Why?
|
| Tretinoin | 1 | 2003 | 13 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2003 | 12 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 33 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2003 | 72 | 0.050 |
Why?
|
| Cell Adhesion Molecules | 2 | 2000 | 15 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1999 | 18 | 0.050 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2001 | 1 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2001 | 30 | 0.050 |
Why?
|
| Humans | 5 | 2016 | 22848 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2001 | 78 | 0.040 |
Why?
|
| Carbazoles | 1 | 2000 | 4 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2000 | 34 | 0.040 |
Why?
|
| Cell Fractionation | 1 | 2000 | 4 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2000 | 24 | 0.040 |
Why?
|
| Time Factors | 2 | 2001 | 1220 | 0.040 |
Why?
|
| Integrin alpha6beta1 | 1 | 1999 | 1 | 0.040 |
Why?
|
| Laminin | 1 | 1999 | 7 | 0.040 |
Why?
|
| Protein Kinase C-delta | 1 | 1999 | 9 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2000 | 305 | 0.040 |
Why?
|
| Receptors, Muscarinic | 1 | 1999 | 3 | 0.040 |
Why?
|
| beta Catenin | 3 | 2003 | 40 | 0.040 |
Why?
|
| Nitroprusside | 3 | 2002 | 4 | 0.030 |
Why?
|
| SOXD Transcription Factors | 1 | 2016 | 1 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 92 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2009 | 33 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2016 | 218 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2016 | 158 | 0.030 |
Why?
|
| alpha Catenin | 2 | 2003 | 2 | 0.030 |
Why?
|
| Nitric Oxide Donors | 2 | 2002 | 7 | 0.020 |
Why?
|
| Phenotype | 2 | 2002 | 254 | 0.020 |
Why?
|
| Caspase Inhibitors | 2 | 2001 | 4 | 0.020 |
Why?
|
| Dimerization | 1 | 2010 | 15 | 0.020 |
Why?
|
| Chromatin | 1 | 2010 | 16 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 54 | 0.020 |
Why?
|
| DNA | 1 | 2010 | 86 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 162 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 1999 | 13 | 0.020 |
Why?
|
| Mutation | 1 | 2010 | 284 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 174 | 0.020 |
Why?
|
| Cytochalasin D | 1 | 2003 | 4 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2003 | 111 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2002 | 6 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 15 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2002 | 36 | 0.010 |
Why?
|
| Hydrolysis | 1 | 2002 | 7 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 44 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 94 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 131 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2001 | 18 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2001 | 25 | 0.010 |
Why?
|
| Pyridines | 1 | 2001 | 27 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2001 | 75 | 0.010 |
Why?
|
| Imidazoles | 1 | 2001 | 51 | 0.010 |
Why?
|
| Embryonic Induction | 1 | 2000 | 1 | 0.010 |
Why?
|
| Receptors, Fibronectin | 1 | 2000 | 1 | 0.010 |
Why?
|
| Isoquinolines | 1 | 2000 | 9 | 0.010 |
Why?
|
| Pyrroles | 1 | 2000 | 15 | 0.010 |
Why?
|
| Indoles | 1 | 2000 | 26 | 0.010 |
Why?
|
| Models, Biological | 1 | 2001 | 273 | 0.010 |
Why?
|
| Bucladesine | 1 | 1999 | 2 | 0.010 |
Why?
|
| Mitogens | 1 | 1999 | 2 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 1999 | 10 | 0.010 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 1999 | 1 | 0.010 |
Why?
|
| Carbachol | 1 | 1999 | 4 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1999 | 6 | 0.010 |
Why?
|
| Protein Kinase C-epsilon | 1 | 1999 | 2 | 0.010 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1999 | 20 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1999 | 115 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1998 | 17 | 0.010 |
Why?
|